Government's £30m puts Darlington on frontline to tackle cancer and dementia
7 Articles
7 Articles
Cancer and dementia patients could see improved treatment with new facility
A new facility in Darlington will be backed by £29.6 million of Government funding, with the aim of maintaining the UK’s lead in RNA science. Patients battling some of the most devastating diseases such as cancer could see improvement in their treatment as a result of a funding boost, a health minister said. A new facility in Darlington will be backed by £29.6 million of Government funding, with the aim of maintaining the UK’s lead in RNA scienc…
New £30M RNA therapy facility helps the fight against cancer and other diseases
A state-of-the-art facility in Darlington is set to fast-track the development of next-generation RNA therapies thanks to nearly £30 million in government funding The newly announced UK RNA Biofoundry will play a crucial role in accelerating the development and production of breakthrough treatments for cancer, heart disease, infectious illnesses, and other severe conditions. Transforming the future of medicine RNA-based therapies are widely seen…
UK to fast-track next-gen RNA therapies with £30m Darlington biofoundry
The government has unveiled plans for a new £29.6 million RNA biofoundry in Darlington, designed to accelerate the development of next-generation therapies for cancer, dementia, cardiovascular disease and infectious illnesses. Backed by the Department for Science, Innovation and Technology (DSIT), the UK RNA Biofoundry will provide scientists and businesses with a dedicated, state-of-the-art facility to manufacture RNA materials at clinical grad…
New facility to test RNA therapies
New facility to test RNA therapies Polly Jones 28 August, 2025 New facility to test RNA therapies 28 August, 2025 A new facility is to open in Darlington, researching new RNA therapies which could help tackle cancer, heart conditions and other diseases.The facility is backed by £29.6 million of government funding.The UK RNA Biofoundry will help UK scientists and businesses working in RNA research to get their ideas out of the laboratory, and …
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium